abbvie_0

AbbVie sue NHS over hepatitis C drug procurement

pharmafile | November 8, 2018 | News story | Business Services AbbVie, NHS, britain, court, hep C, hepatitis, ruling 

American pharma firm AbbVie are suing Britain’s NHS after claiming that the health service’s procurement of hepatitis C drugs breached procurement rules.

AbbVie have claimed that the NHS failed in its duty to treat all bidders fairly after it launched the single largest procurement of medicines ever conducted by the NHS in spring of this year.

The procurement which was launched as part of an effort to lower the price of drugs for hepatitis C, saw NHS England offer three year contracts with the option of extension for an additional two years.

Advertisement

However NHS England has said that the Illinois-based firm’s allegation was “embarrassing for lack of particulars”.

Significantly the court action is set to delay the implementation of the programme. Furthermore, the case has so far been heard in private. However confidentiality restrictions were lifted by Mr Justice Fraser in autumn of this year.

Louis Goss

Related Content

Manchester launches nurse-led clinic to improve kidney transplant outcomes

Manchester University NHS Foundation Trust has launched a specialist nurse-led clinic designed to provide more …

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, has visited …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

The Gateway to Local Adoption Series

Latest content